Literature DB >> 2934472

Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.

M F Lipscomb, C R Lyons, G Nunez, E J Ball, P Stastny, W Vial, V Lem, J Weissler, L M Miller.   

Abstract

Previous studies demonstrated that alveolar macrophages (AM) from most normal human volunteers failed to stimulate the antigen-induced proliferation of peripheral blood T lymphocytes although greater than 90% of AM expressed HLA-DR antigens. The current studies establish that AM also fail to induce allogeneic peripheral blood mononuclear cells to proliferate in a mixed leukocyte reaction (MLR). Suppressive activity by AM was not an explanation for their failure to induce an MLR. Indirect immunofluorescence established the presence of both HLA-DR and DQ antigens on the majority of AM and the persistence of these antigens on cells in culture for up to 6 days, the period of time required to observe a maximal MLR. Metabolic labeling experiments also demonstrated that HLA-DR antigens were synthesized by AM. It was recently reported that AM secrete relatively small amounts of IL 1, an important ancillary signal provided by accessory cells to enhance the stimulation of lymphocyte proliferation. However, addition of optimal concentrations of IL 1 to cultures containing AM failed to enhance the MLR. Thus, there is at least one additional, but as yet undefined, requirement for an accessory cell to induce an optimal MLR besides the display of HLA-D region antigens and the secretion of IL 1. In contrast, AM were effective in specifically stimulating proliferation of alloreactive T cell lines, suggesting that at least some cell lines do not require this nonspecific undefined second signal. We speculate that although AM may not initiate primary immune responses in the lung, they may be important in maintaining immune-mediated inflammatory responses by specifically restimulating already activated T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2934472

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Ontogeny of macrophage subpopulations and Ia-positive dendritic cells in pulmonary tissue of the rat.

Authors:  E P van Rees; M B van der Ende; T Sminia
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

Review 2.  Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung.

Authors:  Vineet Indrajit Patel; Jordan Patrick Metcalf
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 3.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

4.  Immunosuppression by pulmonary surfactant: mechanisms of action.

Authors:  M L Wilsher; D J Parker; P L Haslam
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

5.  Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S W Clarke; L W Poulter
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

6.  Enrichment and characterization of dendritic cells from human bronchoalveolar lavages.

Authors:  C E Havenith; J M van Haarst; A J Breedijk; M G Betjes; H C Hoogsteden; R H Beelen; E C Hoefsmit
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Impaired production and lack of secretion of interleukin 1 by human breast milk macrophages.

Authors:  J L Subiza; C Rodriguez; A Figueredo; P Mateos; R Alvarez; E G de la Concha
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

8.  Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages.

Authors:  Huy A Nguyen; Murugesan V S Rajaram; Douglas A Meyer; Larry S Schlesinger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-10       Impact factor: 5.464

9.  Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis.

Authors:  M G Betjes; C W Tuk; D G Struijk; R T Krediet; L Arisz; R H Beelen
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

Review 10.  Macrophages in tuberculosis: friend or foe.

Authors:  Evelyn Guirado; Larry S Schlesinger; Gilla Kaplan
Journal:  Semin Immunopathol       Date:  2013-07-18       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.